Amanda E. Brooks, Ph.D.
Affiliations: | 2006 | University of Wyoming, Laramie, WY, United States |
Area:
Molecular BiologyGoogle:
"Amanda Brooks"Parents
Sign in to add mentor| David W. Grainger | grad student | University of Utah (BME Tree) | ||
| Randolph V. Lewis | grad student | 2006 | University of Wyoming | |
| (Production and characterization of a synthetic spider silk protein based on the Argiope aurantia MaSp2 sequence.) | ||||
Children
Sign in to add trainee| Kaitlin M Dailey | grad student | 2019-2020 | North Dakota State University (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dailey KM, Small JM, Pullan JE, et al. (2023) An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic. Plos One. 18: e0289183 |
| Roe JM, Seely K, Bussard CJ, et al. (2023) Hacking the Immune Response to Solid Tumors: Harnessing the Anti-Cancer Capacities of Oncolytic Bacteria. Pharmaceutics. 15 |
| Pullan J, Dailey K, Bhallamudi S, et al. (2022) Modified Bovine Milk Exosomes for Doxorubicin Delivery to Triple-Negative Breast Cancer Cells. Acs Applied Bio Materials |
| Mulinti P, Diekjürgen D, Kurtzeborn K, et al. (2022) Anti-Coagulant and Antimicrobial Recombinant Heparin-Binding Major Ampullate Spidroin 2 (MaSp2) Silk Protein. Bioengineering (Basel, Switzerland). 9 |
| Pierce KM, Miklavcic WR, Cook KP, et al. (2021) The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors. Nanomaterials (Basel, Switzerland). 11 |
| Dailey KM, Jacobson RI, Johnson PR, et al. (2021) Methods and Techniques to Facilitate the Development of NT as an Effective, Therapeutic Oncolytic Bacteria. Frontiers in Microbiology. 12: 624618 |
| Dailey KM, Allgood JE, Johnson PR, et al. (2021) The next frontier of oncotherapy: accomplishing clinical translation of oncolytic bacteria through genetic engineering. Future Microbiology |
| Shreffler JW, Pullan JE, Dailey KM, et al. (2019) Overcoming Hurdles in Nanoparticle Clinical Translation: The Influence of Experimental Design and Surface Modification. International Journal of Molecular Sciences. 20 |
| Hoffmann B, Gruat-Henry C, Mulinti P, et al. (2018) Using hydrodynamic focusing to predictably alter the diameter of synthetic silk fibers. Plos One. 13: e0195522 |
| Pullan JE, Pullan AT, Taylor VB, et al. (2016) Energy-triggered drug release from polymer nanoparticles for orthopedic applications. Therapeutic Delivery |